Canada markets open in 1 hour 26 minutes

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.1500-0.0092 (-5.78%)
At close: 04:00PM EDT
0.1552 +0.01 (+3.47%)
Pre-Market: 08:00AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,125
1,096
3,188
33
158.333
-
Operating Expenses
Research Development
17,051
14,489
16,678
14,583
14,359
-
Selling General and Administrative
10,898
10,373
11,100
10,185
10,006
-
Total Operating Expenses
27,949
24,862
27,778
24,768
24,365
-
Operating Income or Loss
-25,824
-23,766
-24,590
-24,735
-24,207
-
Total Other Income/Expenses Net
1,762
824
3,593
1,452
1,760
-
Income Before Tax
-24,062
-22,942
-20,997
-23,283
-22,447
-
Income Tax Expense
-
-
-
-
-
0
Income from Continuing Operations
-24,062
-22,942
-20,997
-23,283
-22,447
-
Net Income
-24,062
-22,942
-20,997
-23,283
-22,447
-
Net Income available to common shareholders
-24,062
-22,942
-20,997
-23,679
-23,240
-
Basic EPS
-0.10
-
-0.10
-0.11
-0.12
-0.13
Diluted EPS
-0.10
-
-0.10
-0.11
-0.12
-0.13
Basic Average Shares
217,166
-
216,811
210,178
196,895
145,195
Diluted Average Shares
217,166
-
216,811
210,178
196,895
145,195